Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

NCT01704599 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped side effect and poor clinical outcome

Conditions

Psoriasis

Interventions

DRUG: Humira Then Humira plus 3 B vitamins

Sponsor

Wayne State University

Collaborators

[object Object]